Search
for
Sort by
Research 211–240 of 1000+
- Repigmentation of hair following adalimumab therapy
- Facial hidradenitis suppurativa: A potential mimicker of acne vulgaris
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- PRIDE syndrome associated with panitumumab treatment – case report and literature review
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- 308 Epidermal keratinocytes regulate bacterial immune responses and host defense through EGFR
- The relevance of collagen XVII expression in epidermal differentiation and proliferation
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- Treatment of acne with intermittent isotretinoin, cohort study
- Cutaneous adverse effects of targeted therapies
- Oxygen, Metabolism, and Regeneration: Lessons from Mice
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils
- Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Scarring hair follicle destruction is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Editors' Picks
- Clinical Snippets
- A Hot New Twist to Hair Biology
- FGF Family: From Drug Development to Clinical Application
- Mechanism of action of herbs and their active constituents used in hair loss treatment
- Vitamins and their derivatives synergistically promote hair shaft elongation ex vivo via PlGF/VEGFR-1 signalling activation